figshare
Browse
Supplemental table 1.docx (19.43 kB)

Supplementary Material: Treatment and Overall Survival Among Anti-PD-1 Exposed Advanced Melanoma Patients with Evidence of Disease Progression

Download (19.43 kB)
dataset
posted on 2021-12-06, 16:19 authored by Cathy Anne Pinto, Xinyue Liu, Xiaoyun Li, Emilie Scherrer, Mizuho Kalabis
Table S1 Patient characteristics by type of index therapy

Funding

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.

History

Usage metrics

    Immunotherapy

    Categories

    Keywords

    Cohort studyadvanced melanomaresistance to immunotherapytreatmentoverall survivalCancer Therapy (excl. Chemotherapy and Radiation Therapy)

    Licence

    CC BY-NC-ND 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC